George Kottayil
CIK: 0001895357
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Grace Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 17, 2026GRCE
Grace Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
12.2K shares- - Jan 8, 2026GRCE
Grace Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
10K shares- - May 9, 2025GRCE
Grace Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
10K shares-
1-3 of 3 transactions
About Kottayil George
Kottayil George (SEC CIK 0001895357) files insider reports with the SEC as Director of Grace Therapeutics, Inc. (GRCE).
Signal8 holds 3 ownership filings by Kottayil George, all Form 4s, filed between May 13, 2025 and Sep 21, 2026. Those filings report 3 transactions, from May 9, 2025 to Sep 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kottayil George's filings is in PRINCETON, NJ.
Recent filings by Kottayil George
Other insiders filing for Grace Therapeutics, Inc. (GRCE)
- Opaleye Management Inc., 10% Owner
- NEUGEBOREN EDWARD, Director
- DAVIS A BRIAN, Director
- Kavuru Vimal, Director
- Kohli Prashant, Chief Executive Officer
- Kumar Amresh, VP Program Management